Annual CAPEX
$312.00 K
-$8.04 M-96.27%
December 31, 2021
Summary
- As of February 10, 2025, CLVS annual capital expenditures is $312.00 thousand, with the most recent change of -$8.04 million (-96.27%) on December 31, 2021.
- During the last 3 years, CLVS annual CAPEX has fallen by -$63.93 million (-99.51%).
Performance
CLVS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CAPEX
$89.00 K
+$43.00 K+93.48%
September 30, 2022
Summary
- As of February 10, 2025, CLVS quarterly capital expenditures is $89.00 thousand, with the most recent change of +$43.00 thousand (+93.48%) on September 30, 2022.
- Over the past year, CLVS quarterly CAPEX has stayed the same.
Performance
CLVS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
$266.00 K
$0.000.00%
September 30, 2022
Summary
- As of February 10, 2025, CLVS TTM capital expenditures is $266.00 thousand, unchanged on September 30, 2022.
- Over the past year, CLVS TTM CAPEX has dropped by -$237.00 thousand (-47.12%).
Performance
CLVS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
CLVS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -96.3% | 0.0% | -47.1% |
| 3 y3 years | -99.5% | -93.7% | -98.6% |
| 5 y5 years | -92.4% | -46.7% | -98.6% |
CLVS CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -48.3% | -14.7% | -3.8% |
| 5 y | 5-year | -98.4% | at low | -98.9% | -78.7% | -98.6% | -3.8% |
| alltime | all time | -99.5% | at low | -99.8% | -167.4% | -99.7% | -17.3% |
Clovis Oncology CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $89.00 K(+93.5%) | $266.00 K(0.0%) |
| Jun 2022 | - | $46.00 K(-25.8%) | $266.00 K(+3.9%) |
| Mar 2022 | - | $62.00 K(-10.1%) | $256.00 K(-17.9%) |
| Dec 2021 | $312.00 K(-96.3%) | $69.00 K(-22.5%) | $312.00 K(-38.0%) |
| Sep 2021 | - | $89.00 K(+147.2%) | $503.00 K(+16.2%) |
| Jun 2021 | - | $36.00 K(-69.5%) | $433.00 K(-94.9%) |
| Mar 2021 | - | $118.00 K(-54.6%) | $8.44 M(+1.0%) |
| Dec 2020 | $8.35 M(-56.1%) | $260.00 K(+1268.4%) | $8.35 M(-1.7%) |
| Sep 2020 | - | $19.00 K(-99.8%) | $8.50 M(-14.0%) |
| Jun 2020 | - | $8.04 M(>+9900.0%) | $9.88 M(+247.6%) |
| Mar 2020 | - | $34.00 K(-91.6%) | $2.84 M(-85.1%) |
| Dec 2019 | $19.04 M(-70.4%) | $403.00 K(-71.3%) | $19.04 M(-5.3%) |
| Sep 2019 | - | $1.40 M(+39.9%) | $20.12 M(-17.1%) |
| Jun 2019 | - | $1.00 M(-93.8%) | $24.27 M(-69.8%) |
| Mar 2019 | - | $16.23 M(+997.4%) | $80.26 M(+24.9%) |
| Dec 2018 | $64.24 M | $1.48 M(-73.4%) | $64.24 M(+2.2%) |
| Sep 2018 | - | $5.55 M(-90.3%) | $62.83 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $56.99 M(>+9900.0%) | $57.45 M(+8724.3%) |
| Mar 2018 | - | $217.00 K(+205.6%) | $651.00 K(-84.1%) |
| Dec 2017 | $4.10 M(+435.5%) | $71.00 K(-57.5%) | $4.10 M(+0.0%) |
| Sep 2017 | - | $167.00 K(-14.8%) | $4.10 M(+5.9%) |
| Jun 2017 | - | $196.00 K(-94.7%) | $3.87 M(+1.1%) |
| Mar 2017 | - | $3.67 M(+5140.0%) | $3.83 M(+400.0%) |
| Dec 2016 | $766.00 K(-74.8%) | $70.00 K(-216.7%) | $766.00 K(-70.0%) |
| Sep 2016 | - | -$60.00 K(-139.5%) | $2.56 M(-8.2%) |
| Jun 2016 | - | $152.00 K(-74.8%) | $2.79 M(-1.3%) |
| Mar 2016 | - | $604.00 K(-67.5%) | $2.82 M(-7.0%) |
| Dec 2015 | $3.04 M(+32.8%) | $1.86 M(+1000.6%) | $3.04 M(+139.0%) |
| Sep 2015 | - | $169.00 K(-11.1%) | $1.27 M(-8.2%) |
| Jun 2015 | - | $190.00 K(-76.7%) | $1.38 M(-52.0%) |
| Mar 2015 | - | $816.00 K(+758.9%) | $2.88 M(+26.1%) |
| Dec 2014 | $2.29 M | $95.00 K(-66.3%) | $2.29 M(+4.3%) |
| Sep 2014 | - | $282.00 K(-83.3%) | $2.19 M(+14.8%) |
| Jun 2014 | - | $1.69 M(+667.7%) | $1.91 M(+767.7%) |
| Mar 2014 | - | $220.00 K | $220.00 K |
FAQ
- What is Clovis Oncology annual capital expenditures?
- What is the all time high annual CAPEX for Clovis Oncology?
- What is Clovis Oncology annual CAPEX year-on-year change?
- What is Clovis Oncology quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Clovis Oncology?
- What is Clovis Oncology quarterly CAPEX year-on-year change?
- What is Clovis Oncology TTM capital expenditures?
- What is the all time high TTM CAPEX for Clovis Oncology?
- What is Clovis Oncology TTM CAPEX year-on-year change?
What is Clovis Oncology annual capital expenditures?
The current annual CAPEX of CLVS is $312.00 K
What is the all time high annual CAPEX for Clovis Oncology?
Clovis Oncology all-time high annual capital expenditures is $64.24 M
What is Clovis Oncology annual CAPEX year-on-year change?
Over the past year, CLVS annual capital expenditures has changed by -$8.04 M (-96.27%)
What is Clovis Oncology quarterly capital expenditures?
The current quarterly CAPEX of CLVS is $89.00 K
What is the all time high quarterly CAPEX for Clovis Oncology?
Clovis Oncology all-time high quarterly capital expenditures is $56.99 M
What is Clovis Oncology quarterly CAPEX year-on-year change?
Over the past year, CLVS quarterly capital expenditures has changed by $0.00 (0.00%)
What is Clovis Oncology TTM capital expenditures?
The current TTM CAPEX of CLVS is $266.00 K
What is the all time high TTM CAPEX for Clovis Oncology?
Clovis Oncology all-time high TTM capital expenditures is $80.26 M
What is Clovis Oncology TTM CAPEX year-on-year change?
Over the past year, CLVS TTM capital expenditures has changed by -$237.00 K (-47.12%)